Results 231 to 240 of about 427,029 (392)

Treatment Cessation in Chronic Myeloid Leukemia: Evidence and Uncertainties. [PDF]

Hematol Oncol
Mayer J.
europepmc   +1 more source

Plasma levels of Human Granulocytic Elastase-alpha-Proteinase Inhibitor Complex (E-alpha1PI) in Leukemia [PDF]

, 1984
Hiller, E., Jochum, Marianne
core  

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

Leukemia, 2019
S. Branford, S. Branford, S. Branford, D. Kim, J. Apperley, C. Eide, C. Eide, S. Mustjoki, S. T. Ong, S. T. Ong, Georgios Nteliopoulos, T. Ernst, C. Chuah, C. Chuah, C. Gambacorti-Passerini, M. Mauro, B. Druker, B. Druker, Dong-Kee Kim, F. Mahon, J. Cortes, J. Radich, A. Hochhaus, T. Hughes, T. Hughes   +24 more
semanticscholar   +1 more source

Vitexin Attenuates the Growth and Glycolysis of Acute Myeloid Leukemia Cells by Suppressing the HIF‐1α‐Modulated YAP Pathway Under Hypoxic Conditions

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Vitexin, an apigenin flavone glycoside, exhibits antitumor activity against various cancers including leukemia. Hypoxia enhances glycolysis, thereby promoting tumor growth. In this study, we aimed to explore the effects of vitexin on hypoxia‐induced growth and glycolysis in acute myeloid leukemia (AML) cells and determine the underlying ...
Ping Wang, Jia‐Jia Zhang, Fang Zhang, Xiao‐Jie Qu, Hui Zhang   +4 more
wiley   +1 more source

HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemia. [PDF]

Hemasphere
Toulemonde C, Dubois V, Bouvier C, Ridao A, Archier MC, Balsat M, Ducastelle S, Barraco F, Fossard G, Hildt J, Bollard J, Michallet M, Labussière-Wallet H, Hayette S, Nicolini FE, Alcazer V.   +15 more
europepmc   +1 more source

Growth inhibitory effects of crude pomegranate peel extract on chronic myeloid leukemia, K562 cells

, 2015
Muhammad Farid Johan, MatJusoh Siti Asmaa, Al-JamalHamid Ali, Azman Seeni   +3 more
openalex   +1 more source

Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring

American journal of hematology/oncology, 2018
E. Jabbour, H. Kantarjian
semanticscholar   +1 more source

Peripheral versus Marrow Lipidomics in Patients with Severe Aplastic Anemia: Potential Indicators for Early Immunosuppressive Treatment Response

Lipids, EarlyView.
ABSTRACT This study aimed to explore the differences of peripheral blood (PB) and bone marrow serum lipidomic profiles in severe aplastic anemia (SAA) patients and their significance in predicting earlier immunosuppressive therapy (IST) response. A cohort of 11 newly diagnosed SAA patients and 15 healthy controls were enrolled between June 2020 and ...
Zexing Sun, Yilei Hong, Yaonan Hong, Chuanao Xin, Qi Liu, Huijin Hu, Yingying Shen, Ying Chen, Shan Liu, Yiping Shen, Yuhong Zhou, Dijiong Wu   +11 more
wiley   +1 more source

Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance. [PDF]

Oncol Res
Bera R, Ochi Y, Huang YJ, Kuo MC, Yoshida K, Ogawa S, Shih LY.   +6 more
europepmc   +1 more source

An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States

, 2018
Vivek Kumar, Mohit Garg, Neha Chaudhary, Abhinav Chandra   +3 more
openalex   +1 more source